Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has shared an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has announced plans for a proposed placing of new H shares and a proposed sale of existing H shares by its controlling shareholder. The proposed placing involves issuing new H shares to certain investors under a general mandate, with terms to be determined through a book-building exercise. The proposed sale involves the controlling shareholder disposing of certain existing H shares. These two transactions are independent of each other and may not occur simultaneously. No binding agreements have been made yet, and the company advises investors and shareholders to exercise caution.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing innovative medical robotic solutions.
Average Trading Volume: 10,523,140
Technical Sentiment Signal: Buy
Current Market Cap: HK$19.32B
See more data about 2252 stock on TipRanks’ Stock Analysis page.